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To determine the difference in age-specific immunopro-
tection during waves of influenza epidemics, we analyzed 
excess  monthly  death  data  for  the  1918–1920  influenza 
pandemic in Taiwan. For persons 10–19 years of age, per-
centage of excess deaths was lowest in 1918 and signifi-
cantly higher in 1920, perhaps indicating lack of immuno-
protection from the first wave.
R
ecent studies have focused on quantifying the global 
effects of the influenza pandemic of 1918–1920 (1–3). 
This pandemic swept through Taiwan in 2 waves, at the 
end of 1918 and again in early 1920, causing devastating 
loss of human life. A report about the devastation brought 
by the first wave of the influenza epidemic, published in 
February 1920 (4), indicated that as of December 15, 1918, 
a total of 779,522 persons (20.8% of the population) had 
been infected and 25,394 persons had died from influenza; 
case-fatality rate was 3.26% (4,5). Although the number of 
infections decreased dramatically in early 1919, a second 
wave of the epidemic at the end of that year created another 
severe death toll.
Previous studies have shown that excess deaths, similar 
to those noted in the temperate zones, were also observed 
in Taiwan, which is in a tropical–subtropical zone, during 
periods of previously recognized influenza epidemics (6,7). 
A recent study has also shown Taiwan to be an evolution-
arily leading region for global circulation of influenza vi-
rus A (H3N2) (8). Therefore, we analyzed the 1918–1920 
pandemic in Taiwan to contribute to understanding of and 
preparation for possible future pandemic events.
The Study
Using data from the 1895–1945 Statistical Abstract 
of Taiwan (9), we compared monthly deaths during the 2 
waves of epidemics in 1918 and 1920 with deaths during 
corresponding nonpandemic periods of the adjacent years. 
For example, we compared monthly deaths for November 
and December 1918 with the mean deaths for November 
and  December  1916–1917  and  1919–1922.  Statistically 
significant excess deaths were computed by detecting the 
data points at which the all-cause deaths exceeded the mean 
of the adjacent years +2 SDs (6,10). Excess deaths, com-
puted from the mean number of deaths at these data points, 
were then used to ascertain the effect of the pandemic on 
deaths during these periods. During 1918–1920, population 
data were divided into 3 major groups: Taiwanese (95.2%), 
Mainland Chinese (0.57%), and Japanese–Korean (4.2%). 
However, only records of all-cause deaths for Taiwanese 
and Japanese were available and used in our analysis.
Figure 1 gives the mean monthly number of all-cause 
deaths and 95% confidence intervals (CIs) for each month 
during 1916–1922, excluding the known anomaly months 
(the 2 epidemic waves) of November–December 1918 and 
January–February 1920. The number of deaths increased 
markedly during the anomaly months. When we plotted 
the anomaly points against the actual number of deaths, we 
noted that the anomaly points were significantly >2 SDs 
above the means and that substantial excess deaths had in-
deed occurred. Moreover, we estimated the excess deaths 
during these 2 waves by subtracting the mean number of all-
cause deaths from the number of deaths during the anomaly 
periods (Table 1). Because the 2 waves of epidemics had 
overlapped the adjacent months, we also included increases 
during these months.
We used age-specific data on deaths to quantify the 
effect of the 1918–1920 influenza pandemic on each age 
group. Because monthly age-specific death data were not 
available (9), we used yearly age-specific all-cause death 
data  to  quantify  age-specific  excess  deaths  during  1918 
and 1920. Figure 2, panel A, gives the age-specific per-
centages of all-cause deaths of Taiwanese persons during 
1917–1921 only. The percentages of all-cause deaths by 
age group were computed for 1918 and 1920 and compared 
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Figure 1. Monthly all-cause and excess death rates, Taiwan, July 
1916  through  June  1922.  Monthly  averages  for  excess  deaths 
exclude those of the pandemic years 1918 and 1920. Bars indicate 
excess deaths per 100,000 population during the pandemic months 
of November–December 1918 and January–February 1920.with the respective averages of percentages for the adjacent 
years (1917, 1919, and 1921).
For persons 5–39 years of age, percentages of all-cause 
deaths for 1918 and 1920 were clearly higher than those 
for the average of adjacent years; for persons >55 years 
of age, they were lower. In addition, deaths were higher 
in 1918 than in 1920 for persons 25–39 years of age, but 
deaths were higher in 1920 for those 5–24 years of age. 
The excess percentages of deaths for 1918 and 1920 in age 
groups 10–19, 20–29, and 30–39 years were computed by 
subtracting the average percentages of deaths in these age 
groups during the adjacent years from the respective true 
percentages of deaths in these age groups during 1918 and 
1920 (Table 2).
The percentages of excess deaths were most significant 
for persons 20–39 years of age in 1918 and 10–29 years of 
age in 1920. When we compared the 1918 and 1920 waves, 
the percentage of excess deaths decreased during the sec-
ond wave for persons 30–39 years of age, was almost iden-
tical for those 20–29 years of age, and was significantly 
higher for those 10–19 years of age. Even for those 5–9 
years of age, the percentage of deaths was higher during 
1920 than either during 1918 or for the average of adjacent 
years (Figure 2, panel A).
Our  estimate  of  1.38%  (95%  CI  1.14–1.68)  excess 
deaths for Taiwan is close to the estimate of 1.44% (95% 
CI 1.40–1.48) by Murray et al. (3). However, their esti-
mate was based on calculations of 3-year excess deaths for 
1918–1920 over the preceding 3 (1915–1917) and the fol-
lowing 3 years (1921–1923). During 1919–1920, a cholera 
outbreak caused 2,693 deaths in 1919 and 1,675 deaths in 
1920, which might have skewed their estimate of excess 
deaths for Taiwan. In contrast, our 1920 estimate, obtained 
by using higher resolution monthly data (more precise than 
yearly data), accounted for only the first 3 months of the 
year. Although the exact months of the cholera outbreak 
are unknown, we can reasonably assume that the excess 
deaths caused by cholera during these 3 months were sub-
stantially fewer than excess deaths from the entire cholera 
outbreak during 1919–20.
Ample  literature  describes  the  unusual  age-specific 
death patterns for the 1918–1920 pandemic (11–13). To 
compare the age-specific differences between the 2 waves, 
we compared the percentages of all-cause deaths of per-
sons 10–39 years of age in 1918 with the corresponding 
percentages of all-cause deaths for the same groups of per-
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Table 1. Excess all-cause deaths of Taiwanese and Japanese persons during 2 influenza epidemic waves in Taiwan, 1918–1920* 
Time period 
Observed no. 
deaths
Expected
no. deaths†  SD Excess no. deaths (95% CI) 
Excess no. deaths, by wave‡ 
(95% CI) 
First wave 
  1918 Oct§   8,725  8,366 489 359 (0–1,337)¶ 
  1918 Nov 23,156 8,042 768 15,114 (13,578–16,650)
  1918 Dec 17,658 8,224 793 9,434 (7,848–11,021)
24,907
(21,426–29,008) 
Second wave 
  1919 Dec§   9,319  8,224 793 1,095 (0–2,682)¶ 
  1920 Jan 23,906 8,478 973 15,429 (13,482–17,375) 
  1920 Feb 16,466 7,466 955 9,001 (7,090–10,911) 
  1920 Mar§   8,625  8,009 630 616 (0–1,877)¶ 
26,141
(20,572–32,845) 
*CI, confidence interval.  
†Expected monthly no. deaths was computed from mean no. deaths for that month during 1916–1922, excluding the epidemic month. Total excess no. 
deaths for these 2 periods = 51,048 (95% CI 41,998–61,853). 
‡Including the excess no. deaths in adjacent months. 
§Excess no. deaths for these months are not statistically significant (i.e., not >2 SD above mean). 
¶Max (0, lower bound).
Figure  2.  A)  Percentages  (in  log  scale)  of  all-cause  deaths  in 
Taiwan, by age group. Error bars indicate 95% confidence intervals. 
B) Percentages of all-cause deaths for persons 10–39 years of age 
in 1918, grouped by 5-year age groups. Excess Deaths during 1918–1920 Pandemic, Taiwan
sons, who 2 years later were 12–41 years of age (Figure 2,   
panel B).
Within  the  10–39-year  age  group  in  1918,  the  age 
groups with the lowest percentage of excess all-cause deaths 
in 1918 (10–19 years) had markedly increased deaths in 
1920, and the age groups with a higher percentage of ex-
cess all-cause deaths in 1918 (30–39 years) had noticeably 
decreased deaths in 1920 (Table 2; Figure 2, panel B). This 
finding could be explained in part by acquired immuno-
protection by those age groups during the first wave, thus 
giving credence to the belief that the 2 waves were caused 
by the same virus strain.
Conclusions
In 1918, the epidemic swept through all 12 adminis-
trative districts on the island in <1 month. Given that the 
population of Taiwan has increased >6-fold since then and 
that the current population is much more mobile and trav-
els more, a future outbreak of a similarly virulent influenza 
virus strain could conceivably spread through the island in 
a few days. The total estimated number of excess deaths is 
51,048 (95% CI 41,998–61,853). Given the average Taiwan 
population size during 1918–1920, the percentage of excess 
deaths was 1.38% (95% CI 1.14–1.68). Given the popula-
tion of Taiwan at the end of 2007, the number of persons 
killed by an epidemic of similar magnitude today would be 
≈315,000 (95% CI 259,900–384,000). Pandemic readiness 
planning for Taiwan, or any other country, must consider 
the potential magnitude of a similar-sized pandemic.
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Table 2. All-cause deaths for Taiwanese persons during 1916–1922, by age group, and excess percentages of age-specific deaths for
1918 and 1920* 
Age group, y 
10–19 20–29 30–39
Year 
Total no. 
deaths
No. (%) 
deaths
Excess % deaths 
(95% CI)
No. (%)  
deaths
Excess % deaths 
(95% CI)
No. (%)  
deaths
Excess % deaths 
(95% CI)
1918 124,677 5,836 (4.68) 0.19 (0–0.48)‡ 11,028 (8.85) 1.88† (1.1–2.67) 14,804 (11.87) 2.78† (0.02–5.54)
1920 119,477 6,888 (5.77) 1.27† (0.09–0.56) 10,579 (8.85) 1.89† (1.11–2.68) 12,305 (10.30) 1.20 (0–3.96)‡
*CI, confidence interval. 
†The excess percentages for these age groups are statistically significant. 
‡Max (0, lower bound).
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